1. Home
  2. ECOR vs LOAN Comparison

ECOR vs LOAN Comparison

Compare ECOR & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • LOAN
  • Stock Information
  • Founded
  • ECOR 2005
  • LOAN 1989
  • Country
  • ECOR United States
  • LOAN United States
  • Employees
  • ECOR N/A
  • LOAN N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LOAN Real Estate Investment Trusts
  • Sector
  • ECOR Health Care
  • LOAN Real Estate
  • Exchange
  • ECOR Nasdaq
  • LOAN Nasdaq
  • Market Cap
  • ECOR 40.1M
  • LOAN 58.6M
  • IPO Year
  • ECOR 2018
  • LOAN 1999
  • Fundamental
  • Price
  • ECOR $5.19
  • LOAN $5.17
  • Analyst Decision
  • ECOR Strong Buy
  • LOAN
  • Analyst Count
  • ECOR 2
  • LOAN 0
  • Target Price
  • ECOR $25.50
  • LOAN N/A
  • AVG Volume (30 Days)
  • ECOR 122.7K
  • LOAN 15.7K
  • Earning Date
  • ECOR 05-07-2025
  • LOAN 04-24-2025
  • Dividend Yield
  • ECOR N/A
  • LOAN 8.85%
  • EPS Growth
  • ECOR N/A
  • LOAN N/A
  • EPS
  • ECOR N/A
  • LOAN 0.48
  • Revenue
  • ECOR $25,182,000.00
  • LOAN $7,291,468.00
  • Revenue This Year
  • ECOR $32.20
  • LOAN N/A
  • Revenue Next Year
  • ECOR $46.27
  • LOAN $2.18
  • P/E Ratio
  • ECOR N/A
  • LOAN $10.67
  • Revenue Growth
  • ECOR 57.09
  • LOAN N/A
  • 52 Week Low
  • ECOR $5.02
  • LOAN $4.74
  • 52 Week High
  • ECOR $19.49
  • LOAN $6.05
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 31.29
  • LOAN 45.61
  • Support Level
  • ECOR $6.01
  • LOAN $5.04
  • Resistance Level
  • ECOR $7.14
  • LOAN $5.20
  • Average True Range (ATR)
  • ECOR 0.80
  • LOAN 0.12
  • MACD
  • ECOR 0.07
  • LOAN 0.02
  • Stochastic Oscillator
  • ECOR 3.99
  • LOAN 36.11

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: